The mechanistic link between obese parents and obese offspring and the relative role of genes, and a shared environment is not completely understood. Animal models help us to differentiate between genetic and environmental factors, and the interaction between the two. However, the willingness of researchers to blend results from multiple models makes it difficult for clear mechanisms to be identified for specific hypothesis-driven research. As such we conducted a systematic review of animal models of maternal high fat feeding in an effort to identify the affect on the offspring glycaemic control. Maternal and offspring outcomes are reported in an effort to identify possible relationships to facilitate and focus on future research. We present here data from 11 studies investigating glycaemic control in offspring exposed to a high fat diet (HFD) during maternal gestation only or gestation and lactation. Studies in this review identify a real risk of type 2 diabetes and obesity in male offspring exposed to a maternal HFD. Poor glycaemic control in the offspring appears to be independent of maternal obesity, birth weight or postweaning macronutrient intake. Inconsistencies between studies however, limit our capacity to identify mechanisms for the developmental origin of these diseases in animal models of overnutrition.
Introduction
Children of obese parents are more than twice as likely to be obese themselves in adulthood. 1 Infants of obese mothers show early indicators of obesity predisposition including increased body mass index, elevated body fat content and reduced 24 h energy expenditure. 2 Obesity develops from interplay between environment, behavioural choice and genetic predisposition. An energy imbalance between high caloric food intake and low energy expenditure is compounded by altered gene expression of key hormonal signalling pathways and fuel utilization systems. The mechanistic link between obese parents and obese offspring, and the relative role of genes and a shared environment is not yet completely understood. However, recent data suggest that the environment experienced in utero by offspring of obese women may have an important role. Such an environment may include exposure to maternal hyperglycaemia and hyperinsulinaemia. For example, it has been shown in humans that maternal hyperglycaemia during pregnancy is associated with a greater risk of obesity in children, independent of birth weight. 3, 4 There is also evidence to suggest that maternal body composition per se is a driving factor in offspring adiposity 5 and hence, obesityassociated plasma markers, such as leptin and plasma lipids may also be relevant. The developmental origins of diseases, such as obesity, cardiovascular disease, type 2 diabetes and increased central adiposity in humans have been known for quite sometime with epidemiological studies, linking early growth to subsequent risk of disease. 6 The initial focus was on the increased risk observed in individuals with a lowbirth weight, and thus the role of under nutrition in utero. However, the environmental stimulus surrounding mothers and unborn children today is more likely that of overnutrition before or during gestation, and there is evidence that a very highbirth weight also increases obesity risk. 7 Recently, many animal models of maternal overnutrition have been developed for investigations on offspring development, and include among them: intra-fetal infusion of glucose to sheep during late gestation; 8 gastric infusions of high fat liquid diet to rats 9 and conventional ad libitum feeding of high fat diets (HFD), [10] [11] [12] [13] [14] [15] HFD supplemented with sweetened condensed milk 16 or a high fat and/or high sugar junk food/cafeteria diet. [17] [18] [19] In all models of maternal overnutrition, detrimental effects, such as hyperphagia, elevated whole body adiposity, elevated tissue triglyceride content, abnormal glucose homeostasis and reduced insulin sensitivity have been observed in the offspring. In most cases, these phenotypic characteristics of the metabolic syndrome are present regardless of the diet consumed by the offspring during postnatal development. 11, 17, 18 Taken together, these studies identify a real risk of obesity and insulin resistance in offspring of mothers consuming a HFD during pregnancy. Animal models helps us to differentiate between genetic and environmental factors and the interaction between the two factors. However, the willingness of researchers to blend results from multiple models (such as we have in the paragraph above) makes it difficult for clear mechanisms to be identified for specific hypothesis-driven research. As such we decided to conduct a systematic review of animal models of maternal high fat feeding to identify the affect of this diet on offspring glycaemic control. This review reports maternal and offspring outcomes in an effort to identify possible relationships to facilitate and focus on future research.
Methods
This systematic review was undertaken in accordance with the Cochrane Collaboration Guidelines, Version 5.0.1 Part 2-General Methods for Cochrane Reviews. 20 Before commencement, the focus for the review was defined by the broad research question: what is the effect of a maternal high fat diet on the glycaemic control of male offspring in a rodent population? Eligibility criteria were pre-determined by reviewers to prevent bias in the inclusion or exclusion of articles, and to improve the precision of the broader search (Table 1 ). All studies included in the review were conducted using animal models; specifically, rats not genetically modified or bred to be susceptible to diet-induced obesity. In addition, offspring studies were required to be male.
A HFD was defined as being any diet in which fat, regardless of type or source, constituted greater than 30% of the total energy (kJ) content. The maternal HFD intervention had to be administered freely throughout the entire length of gestation alone, or the gestation and lactation period. Male offspring studied were required to be weaned onto a standard/control diet. Studies were excluded if they did not meet the above definition, or if the macronutrient content of the diet was not specified or ambiguous.
Search terms
The search terms and their synonyms were initially combined with the Boolean operator 'OR', and searched independently as 'search sets'. Search sets were combined with 'AND', so as to yield a sensitive and comprehensive, yet relevant collection of possible articles (Table 2) . It should be noted that although study outcomes were part of the systematic search of the literature for this review, articles were neither included nor excluded on the basis of these outcomes.
Table 1 Eligibility criteria

Inclusion Exclusion
Maternal high fat diet (Fat content 430% of total energy content) intervention during gestation or gestation and lactation.
Diets of unknown dietary composition of protein, fat and carbohydrate.
All obesogenic but non high fat diets (% fat o30% total energy content)
All rat studies Diet interventions not lasting the duration of the gestation. Intragastric feeding models.
Male offspring fed a standard chow/ control diet post weaning.
Comparison between high fat models with no standard control. Low protein diet interventions, maternal under nutrition or intra-uterine growth restriction models. Genetically modified animals (obesity susceptibility/resistance models) All non rodent studies Eligibility criteria used to assess all articles throughout systematic search. Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al
Search strategy
A search of electronic databases included; SCOPUS (all years), MEDLINE (1950-present), Web of Science (all years) and PubMed (all years). The electronic search was conducted with the same search sets in each database with each copied, and pasted into fields to reduce the likelihood of typing errors yielding falsely relevant citations. The final search was the result of the search sets outlined in Table 2 and was conducted on the 4 July 2009. The title, abstract and, where needed, methods section of articles yielded from the electronic search were assessed using the eligibility criteria. Reference lists of relevant articles, were searched and assessed by the same eligibility criteria before being added to the pool of relevant articles.
The final resulting articles were examined by HA and KR and finalized for Methodological Quality Assessment (MQA) (Figure 1 ).
Methodological quality assessment
The finalised literature for review was assessed for quality and validity by a MQA, according to a modified version of the Downs and Black 'Quality Index' (QI). 21 The QI is a series of 27 questions used for MQA of randomized and non-randomized controlled trials, case control and cohort studies in humans. This was developed using epidemiological principles, reviews and existing checklists in 1998. The QI highlights the vulnerabilities in design, Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al with regard to reporting external validity, bias, confounding and power. This tool (as originally designed and published) is not appropriate for the assessment of animal studies that are fundamentally different in design to those recruiting humans. The QI neither does adequately nor reliably highlight the methodological flaws in the reporting of subject characteristics, environment and external validity without explicit questions pertaining to crucial elements of design in animal studies. However, it should be noted that, in regard to animal studies, the remaining areas assessed by the QI that underpin internal validity and fundamental scientific method (bias, confounding and power) are still applicable and should therefore be applied to animal studies with the same rigour. The Downs and Black QI may serve as a good template for the development of an animal study quality assessment tool with proven high internal consistency (KR-20: r ¼ 0.89), good test-retest performance (r ¼ 0.88) and inter-rated performance (r ¼ 0.75). For this reason, literature included in this review was assessed by a modified Downs and Black QI (Table 3) , including more specific questions relating to animals as participants, and the omission of the entire external validity section which, even in humans shows poor reliability (KR-20: r ¼ 0.54). 21 Once modified, this quality rating tool consisted a total of 19 questions, 12 of which assessed the quality of reporting (including animal-specific questions), six assessed internal validity (three each on bias and confounding) and one question assessed the power of each study. Independent MQA was conducted by two researchers (HA and KR). For each study a 'yes' or 'no' response was recorded for each question as either one or zero, respectively. For each study, responses were summed to give a total out of 19, which was then expressed as a percentage.
The comprehensive nature of this assessment leads to the inclusion of questions, which may have a greater bearing on the reliability and validity of the paper being assessed. As such a total score or percentage score given, indicating all positive responses, may not give a true indication of quality. For this reason, in addition to a total score, scores specific to reporting and internal validity were calculated, enabling a more accurate assessment of the validity and reliability of each paper. Additionally, to identify general strengths and weaknesses across the group of papers, responses for each question were also summed to give a total out of 11 questions.
Data collection
For all studies that met the eligibility criteria, all relevant data were extracted. Study protocol, diet intervention, maternal results and offspring outcomes were collected as means and s.e.m. when possible. Maternal and male offspring data were collected for both the experimental group and the control group, so that results could be expressed as a percentage increase or decrease from the respective control group.
Results
Search strategy
Initial electronic searching across four internet-based search engines yielded 1483 citations. The removal of 388 duplicates resulted in 1095 individual articles to be subjected to inclusion and exclusion criteria. With inclusion and exclusion criteria imposed firstly on title and abstract (removal of 963), and secondly on study design and methods (removal of 122), only 10 citations were selected for review. In addition to electronic searching, hand searching of the reference lists of the 10 selected articles was conducted. This method Table 3 Methodological quality assessment questions
Modified downs and black quality index
Reporting General 1 Were the hypotheses/aims/objectives of the study clearly described within the introduction? 2 Were the main outcomes to be measured clearly described in the introduction or methods section?
Animal characteristics 3 Was animal species/ strain identified? 4 Was the animal age at commencement of the study or at conception specified? 5 Have the animal weights at comencement or at conception of study been specified? 6 Have the animal starting numbers, including litter number and sizes been specified? 7 Have the housing details been specified
Design and outcomes
8 Were the interventions of interest clearly described? 9 Were the main findings of the study clearly described? 10 Were estimates of the random variability in the data for the main outcomes provided? 11 Have all important adverse events that may be consequenses of the intervention been reported? 12 Have the actual probability values been reported for the main outcomes, except where probability value is less than 0.001? 
Power
19 Was the paper of sufficient power to detect a clinical important effect where the probability value for a difference being due to chance is less than 5%?
Methodological quality assessment questions modified from Downs and Black (1998).
Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al yielded an additional three articles that were relevant to the review. However after application of the inclusion and exclusion criteria only one qualified for review. Thus, the combination of electronic and hand searching resulted in 11 articles appropriate for review ( Figure 1 ).
MQA
The MQA carried out on all 11 papers included for review is provided in Table 4 . Total score for the QI of each paper can be seen on the far right. The total score for the papers ranged widely, from 26 15 to 74%, 11, 26 with an average quality rating of 57%. Consideration of total rating for reporting and internal validity identifies that overall reporting within the manuscripts was of a higher quality than internal validity ( Table 5 ). The majority (10/11) of studies adequately report species and intervention details. There was however infrequent reporting of maternal weights at conception (5/11). Studies rarely reported potential adverse events (3/11) or potential confounders in study design (1/11), such as discrepancies between sample sizes between analyses, within studies. Of particular note is a complete absence of blinding (0/11) between researchers and animal handling.
Maternal dietary interventions
Maternal dietary characteristics of the individual studies are provided in Table 6 . Fat content of the HFD ranged between 34 and 60% of total energy content of the diet. Most studies (7/11) incorporated saturated fat as the primary source of lipid within the diet. Fat content of the respective control diets ranged from 5 to 17% of the energy content. In most cases, protein content within any study was consistent between HFD (8-21%), and control (14-23%) groups.
Two rat species were used across the 11 studies-Wistar (8 Studies) and Sprague-Dawley (3 Studies). In those studies that reported the age at conception (8/11), there was a very wide range (56-120 days). Furthermore, maternal exposure to a HFD ranged from 21 (gestation only) to 142 days (inclusive of a preliminary pre-mating period, gestation and lactation).
Maternal outcomes
Maternal outcomes are provided in Table 7 . On four occasions, 13, 15, 22, 27 two maternal groups were maintained in the study design. Consequently in Table 7 , 15 specific maternal data sets arise from the original 11 studies included for review. The data presented for the maternal high fat group are expressed as a percentage change relative to the relevant within study control-fed group. Of note, as a result of inconsistencies in study design between studies, data are not available for each outcome listed in Table 7 for every study. Results of the methodological quality assessment (Table 3) conducted on all articles included for analysis in this systematic review. Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al
Maternal anthropometric outcomes
For the purpose of this review, maternal obesity before conception was assumed if studies reported a significant increase in body weight or adiposity in comparison to their respective control dams. Body weight at conception was recorded for only seven maternal data sets, and observed to be significantly elevated compared with control-fed pregnant mothers (5-23%) on four occasions. These four occasions, 22, [24] [25] [26] all used a feeding regime of at least 35 days before conception. Maternal adiposity before conception was reported for three data sets. This was assessed either directly by Dual Energy X-ray Absorptiometry, 22 or indirectly by fasting plasma leptin concentration. 24 Substantial and significant increases in adiposity, compared with control were recorded in two data sets. Both of these data sets also reported elevated maternal body weight and had used preliminary HFD before mating. In the data set that did not observe elevated maternal adiposity compared with control mothers, a preliminary HFD period was not used.
Maternal body weight at gestation day 21, and gestational weight gain were reported for eight data sets. Five of these reported a significant increase (5-21%) in maternal body weight compared with pregnant controls at the time of delivery. This was not always attributable to elevated gestational weight gain. However, the majority of studies either did not report maternal body weight, or observed no significant increase in weight gain with maternal HFD.
Maternal metabolic outcomes Leptin. Four data sets are provided for plasma leptin, two 23, 24 identifying a large and significant increase in response to high fat feeding. It should be noted however, that these measures were taken at different stages of the protocol, one premating, 24 and the other during gestation. 23 The remaining two data sets reported no significant difference in dams on a HFD compared with pregnant controls, but these levels were recorded during lactation.
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Insulin. Fasting plasma insulin was measured before mating for two data sets, and was significantly elevated compared with pregnant controls. 24, 26 Plasma insulin remained elevated when measured subsequently during gestation. 26 Of note however, these data sets all followed at least 35 days of HFD before conception. Three data sets that measured plasma insulin during gestation that used no pre-mating HFD period 12, 23 or only 7 days of HFD before conception 28 reported no change compared with control-fed mothers. When measured, plasma insulin during lactation 22, 28 was significantly elevated (15-137%), following maternal HFD. This was observed in mothers irrespective of any pre-mating HFD period, and occurred while the animals were still on HFD during lactation. Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al
Glucose. Maternal glycaemic control was a seldom-reported outcome. No dynamic assessments were reported, such as oral or intra-peritoneal glucose tolerance tests (IPGTT). Only two data sets are available for fasting plasma glucose before conception, four data sets are available during gestation and one data set is reported during lactation. Fasting plasma glucose was not elevated before conception despite prior HFD for 35 days, 24 or 100 days. 26 Plasma glucose measured during gestation was elevated by 14% after 14 days of HFD, 12 and by 34% at gestational day 21 (121 days of HFD). 26 This was not a consistent result however because two other studies reported no significant change in plasma-glucose levels during gestation 23, 28 despite over 19 days of HFD.
Maternal plasma glucose measured during lactation was elevated (16%) following 43 days of HFD. 28 
Offspring outcomes
Offspring outcomes are provided in Table 8 . In addition to multiple offspring groups resulting from specific maternal interventions, multiple offspring data sets resulted from specific-timed data collection points (neonate, weaning and adulthood). Hence, from the original 11 studies that provided 15 maternal data sets, there are 20 offspring data sets reported in Table 8 . The data presented are from those offspring from each maternal high fat group, and differences relative to each study control-fed group are expressed as a percentage. Of note, as before, as a result of inconsistencies in study design between studies, data are not available for each outcome listed in Table 8 for every study.
Offspring neonatal outcomes
The number of offspring delivered per litter size was not altered by a maternal HFD in four of the five data sets where data was available. The remaining one data set 11 reported a 20% decrease in the number of pups delivered following high fat feeding. There was very little consistency between study designs in regard to litter size during lactation with numbers ranging from 6 to 12 pups per dam (Table 7) . Birth weight of pups of HFD mothers and control-fed mothers was similar in 10 of the 12 data sets that reported birth weight. Only one study (containing two data sets) showed a significant difference in birth weight. 22 It reported low birth weight pups to mothers that consumed HFD for either 21 days (gestation only), or 119 days (HFD feeding before and during gestation). 22 In neonates (post-natal day 0 or 1), there were three data sets examining glycaemic control as indicated by fasting blood glucose, and fasting plasma insulin. Only one of these 28 expressed this data as an insulin:glucose (I:G ratio), an indicator of insulin resistance. The I:G ratio was significantly elevated in pups exposed to a maternal HFD.
In the other two data sets, disparate results are apparent. Srinivasan et al. 26 observed significantly elevated insulin for comparative glycemia between groups and hence as an I:G ratio this study supports the earlier study of Guo et al. 
28
Abbreviations: Age, age at conception; BC, body composition F w, total body fat percentage (DEXA/DXA); *, plasma Leptin; Bdy Wt, body weight; FBG, fasting blood glucose; FPL, fasting plasma leptin; G, gestation period; (g), measure during gestation; GD21 Wt, body weight of dams at gestation day 21; Gr, study group; HFD Pre, days consumed a HFD prior to conception; L, lactation period; (L), Measured during lactation; n, maternal experimental group n; NS, not significant; PD, Post Delivery; PFI, fasting plasma insulin; SD, Sprague-Dawley; Sp, rat species; Total, total days of HFD; WS, Wistar; Wt Gain, maternal weight gain; (mx) or (kx), percent increase or decrease from control; (m) or (k), reported increased or decreased with no magnitude; (F), not recorded. The italicized text above explains the bold values in the table.
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Offspring weanling outcomes
Weanling weights (20-22 days of age), displayed significant increases of 4-43% for 6 of the 13 data sets where data were available. All but one of these weanling groups was exposed to HFD, during both gestation and lactation. Wean weights were not significant between groups in five other data sets. However, the two remaining data sets that showed reduced wean weights in offspring of HFD mums were also from the studies that exposed dams to a HFD during gestation and lactation. 15, 25 Body composition data are provided for three data sets at weaning. All three studies observed significantly elevated adiposity assessed by fat pad mass, 23, 24 or carcass homogenization. 28 All three data sets originated from mothers consuming HFD during gestation and lactation. At weaning, glucose tolerance is reduced in offspring of high fat fed mothers. This is observed following either an oral glucose bolus 23 or an i.p., glucose bolus. 24 Furthermore, in the study of Tamashiro et al., 23 plasma insulin was also significantly elevated throughout the oral glucose tolerance test (OGTT) in 21-day-old male offspring of mothers that had consumed a HFD during gestation and lactation. Of note, two other data sets that provide fasting blood glucose and insulin values for weanling animals, 15, 28 do not support reduced glucose tolerance in offspring fed a HFD in utero. The study of Guo et al. 28 reports I:G ratio to be no different between groups, and the study of Cerf et al., 15 observes a reduced I:G ratio (improved glucose tolerance) in the offspring of dams fed a HFD.
Offspring post-weaning outcomes Body weight and composition. Post-weaning body weight data are available for offspring at 70, 90, 98, 110, 120 and 175 days of age. Body weight was similar between groups across all data sets and ages with the exception of one, 26 that reported body weight to be elevated by 33% in offspring of HFD mums at the only time measured (120 days). Direct measures of adiposity are available for offspring at 70, 90, 110 and 160 days of age. Fat mass, when assessed as fat pad mass relative to body weight 23 or by bioelectrical impedance analysis 13 was not significantly different between groups at 70, or 110 days of age. However, percentage body fat assessed by whole body Dual Energy X-ray Absorptiometry was significantly elevated at 90 11 and 160 days of age 22 in offspring of HFD mothers.
Glycaemic control. Two studies provided measures of glycaemic control at 70 days of age. Ferezou Viala et al. 25 reported homeostatic model assessment scores, calculated 27 and whole-body insulin sensitivity assessed by hyperinsulinaemic-euglycaemic clamp 11 were similar between age-matched, 3-month-old offspring from HFD mothers, and control fed mothers. However, against this, offspring assessed at approximately 90 days of age show hyperinsulinaemia during an OGTT, 11 and both hyperglycaemia and hyperinsulinaemia during an IPGTT. 26 Those offspring that showed hyperinsulinaemia and hyperglycaemia during an IPGTT at 90 days of age also showed fasting hyperinsulinaemia and hyperglycaemia at 120 days of age. 26 However, whole-body insulin sensitivity assessed by hyperinsulinaemic-euglycaemic clamp was similar between the groups at 110 days of age. 13 Insulin resistance, although not directly measured or calculated as an I:G ratio may be inferred in 160-day old animals that show fasting hyperinsulinaemia for comparative glucose levels.
22
Discussion
The aim of this paper was to conduct a systematic review of animal models of maternal high fat feeding to identify its affect on offspring glycaemic control. The only studies included in this review were of female rats, fed a diet for which the energy contribution from fat was over 30%. The diet had to be administered to animals freely during gestation alone, or gestation and lactation. Importantly, offspring groups must have consumed only a standard control or chow diet in the post-weaning period. As such, we present here collective data from 11 studies investigating glycaemic control in offspring exposed to a HFD during maternal gestation only, or gestation and lactation. The search parameters for this review resulted in the inclusion of studies that in some instances included a preliminary period of high fat feeding before conception. This may confound offspring data, especially if maternal obesity developed. Of interest however, is the paucity of data within these individual studies to characterize the maternal metabolic state. One would assume that a comprehensive understanding of the mechanisms for any observations in the offspring would be reliant on a comprehensive understanding of the maternal state.
However, only about half of the studies included for review provided maternal metabolic outcomes, such as maternal weight at conception or maternal insulinaemia, and fewer provided data on maternal body composition or glycaemia. As such we are limited in our capacity to draw strong links between maternal phenotype and offspring development. Given the relative importance of maternal metabolic parameters on offspring development in humans, [3] [4] [5] future animal offspring studies should include these maternal outcomes in an effort to provide mechanistic insights. Furthermore, no two separate studies in the current review have used the same maternal diet with respect to specific energy content or fat type. Additionally, no two studies in the current review have used mothers of a similar age with the exception of two papers that originated from the same maternal intervention. 13, 27 These study design limitations means that grouping of data from all studies presented in this review for a statistical met-analysis would be inappropriate. Potentially, the diversity of study designs presented may provide for some wide reaching insights, given that some uniformity in offspring development is observed despite the disparate maternal study designs.
Irrespective of maternal age, body composition, dietary fat or period of fat feeding, distinct disturbances in offspring glycaemic control were observed. We asked the question, what is the effect of a maternal HFD on the glycaemic control of male offspring in a rodent population? We identified that across the 11 papers reviewed, a number of measures for glycaemic control were used. These included indices derived from static measures of fasting blood glucose and insulin such as the I:G ratio and homeostatic model assessment score in addition to glycosylated haemoglobin. Alternatively, some studies used more dynamic assessments of whole body glucose tolerance (IPGTT or OGTT), and insulin sensitivity (euglycaemichyperinsulinaemic clamp).
The varied assessment tools were implemented at varied ages. At weaning, male offspring of mothers fed a HFD during gestation alone, or gestation and lactation, show poor glucose clearance during either an OGTT or IPGTT. 23, 24 At adolescence (90 days of age), reduced glucose tolerance is observed during an IPGTT 26 or comparative glucose tolerance in the presence of hyperinsulinaemia. 11 In support, static measures of fasting plasma glucose and insulin also show impaired glycaemic control at birth, 26, 28 and adulthood (175 days). 22 Importantly, these observations on glycaemic control are not matched by changes in wholebody insulin sensitivity as assessed by euglycaemic-hyperinsulinaemic clamp at 90 or 110 days of age. 11, 13 The data in Table 8 and the contrasting scores in quality in Tables 4 and 5 , suggest this may be an oversimplification. Altered glycaemic control is not a consistent finding across all of the studies. Furthermore, the data in this review highlights the transient nature of any abnormal glycaemic control that has been observed. For example, offspring of mothers on a HFD that showed an elevated I:G ratio at birth are not significantly different from controls at weaning. 28 Offspring that showed reduced glucose clearance during an OGTT at weaning 23 have normalized by 70 days of age. In contrast to this, the study of Srinivasan et al. 26 observes altered glycaemic control at each of three time points from
Glycaemic control in offspring exposed to a maternal high fat diet H Ainge et al birth through to 120 days of age. These contrasting results are not obviously explained by differences in study design, maternal diet or maternal metabolic state. The studies in this review identify a real risk of poor glycaemic control in offspring of mothers consuming a HFD. It is important to note that across the studies, a decline in glycaemic control was present in offspring from mothers that had been consuming a control diet until gestation and hence consumed a HFD for 21 days in total. A similar decline was present in offspring from mothers who had been consuming HFD for 100 days prior to gestation, as well as during gestation. Additionally, all offspring groups that originated from mothers in which obesity was reported showed some disturbance in glycaemic control. Importantly though, maternal obesity was not a pre-requisite for offspring glycaemic compromise because poor glycaemic control was also observed in offspring from non-obese high fat fed mothers.
The mechanistic links between a maternal HFD and offspring glycaemic control are lacking. Recent studies in mice may provide a focus. Offspring of high fat fed, obese mice having been weaned onto standard laboratory chow, were hyperphagic at 4 weeks of age, and had reduced glucose tolerance at 6 months of age. 16 Activity levels were monitored over a full light/dark 24 h phase, and showed significantly reduced night-time activity of male and female offspring of obese mice at 3 months of age. 16 A sedentary lifestyle could explain elevated offspring adiposity and poor glycaemic control, but none of the rat studies currently reviewed have measures of habitual or spontaneous activity in the offspring. Dysregulation of energy intake would also explain any predisposition to weight gain and obesity in offspring of high fat fed mothers and concomitant changes in glycaemic control. Unfortunately, only three studies reported offspring food consumption data. 22, 25, 27 All three studies agree there is no evidence of elevated food consumption in the offspring of HFD mums. Interestingly, these three studies also observe no changes in indicators of glycaemic control in 70-to 98-day-old offspring.
It is important to note that, of all the studies reviewed here, poor glycaemic control during either an OGTT or an IPGTT was accompanied by either elevated body weight in the offspring, or increased relative body fat content. This review lacks the capacity to identify a timeline of whether or not changes in glycaemic control occur before, or in concert with changes in adiposity. Body composition of offspring is not easily assessed with crude, but simple measures such as body weight. Howie et al. 22 does report an elevated percentage of body fat assessed by dual energy x-ray absorptiometry and fasting hyperinsulinaemia in a 160-day-old offspring of HFD mums despite similar total body weight to control offspring. Body composition data as assessed by dual energy x-ray absorptiometry in the study of Buckley et al. 11 suggests that elevated body fat percentage is more likely a result of reduced lean mass than an increase in fat mass per se.
This is an area of interest for future studies of offspring from HFD mothers. If muscle mass is reduced in offspring, this might be associated with reduced activity levels and altered muscle function. Samuelsson et al. 16 identified offspring of obese mice to have reduced anterior tibialis muscle mass compared with offspring of control-fed mice. A 25% reduction in cross-sectional area, and a 20% reduction in fibre number of the semitendinosus muscle in offspring of junk food-fed mothers, regardless of weaning diet has also been reported. 17 The maximal twitch tension and maximal tetanic tension of the semitendinosus are reduced in offspring of junk food-fed mothers. 29 When expressed relative to muscle mass, force production is decreased in the offspring of junk food-fed rats, regardless of weaning diet. Taken together, these results suggest that offspring of high fat fed/obese mothers have reduced muscle mass, and the muscle they do have are weaker than offspring of control-fed mothers. The studies in this review do not provide direct measures of muscle content or function, but clearly such study is needed to link physical activity, body composition and food intake with offspring and maternal metabolism.
Conclusion
Poor glycaemic control is present in offspring from mothers fed a HFD during gestation alone, or gestation and lactation. This has been associated with elevated adiposity, or reduced lean mass in the offspring. The absence of comprehensive energy consumption or energy expenditure data in the offspring limits our capacity to interpret the influence of post-natal phenotypic, or behavioural changes within the offspring. Sporadic, superficial maternal metabolic and compositional assessment clouds our ability to define the influence of specific maternal metabolic perturbations during early development. Future investigations must focus on the models identified in this review, on quantifying offspring energy expenditure and on delineating body composition in greater detail than just body weight. Future studies should address the transient nature of abnormalities in glycaemic control. Until this is achieved, a more comprehensive understanding of the complex interrelation of energy balance, animal behaviour and in utero environment cannot eventuate. Despite the considerable differences in study design, studies in this review clearly identify a real risk of type 2 diabetes and obesity in offspring exposed to a maternal HFD, and this risk is not dependent on maternal obesity.
